Literature DB >> 27340347

Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Naofumi Mukaida1, Soichiro Sasaki1.   

Abstract

Tumor microenvironments have a crucial role in cancer initiation and progression, and share many molecular and pathological features with wound healing process. Unless treated, tumors, however, do not heal in contrast to wounds that heal within a limited time framework. Wounds heal in coordination of a myriad of types of cells, particularly endothelial cells, leukocytes, and fibroblasts. Similar sets of cells also contribute to cancer initiation and progression, and as a consequence, anti-cancer treatment strategies have been proposed and tested by targeting endothelial cells and/or leukocytes. Compared with endothelial cells and leukocytes, less attention has been paid to the roles of cancer-associated fibroblasts (CAFs), fibroblasts present in tumor tissues, because their heterogeneity hinders the elucidation on them at cellular and molecular levels. Here, we will discuss the origin of CAFs and their crucial roles in cancer initiation and progression, and the possibility to develop a novel type of anti-cancer treatment by manipulating the migration and functions of CAFs.

Entities:  

Keywords:  Angiogenesis; Drug resistance; Extracellular matrix; Immune evasion; Invasion; Metastasis; Transforming growth factor-β

Mesh:

Year:  2016        PMID: 27340347      PMCID: PMC4910652          DOI: 10.3748/wjg.v22.i23.5301

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  131 in total

1.  A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.

Authors:  Kyoko Hida; Michael Klagsbrun
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

2.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

Authors:  H F Dvorak; A M Dvorak; E J Manseau; L Wiberg; W H Churchill
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

3.  Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.

Authors:  Elena Jachetti; Sara Caputo; Stefania Mazzoleni; Chiara Svetlana Brambillasca; Sara Martina Parigi; Matteo Grioni; Ignazio Stefano Piras; Umberto Restuccia; Arianna Calcinotto; Massimo Freschi; Angela Bachi; Rossella Galli; Matteo Bellone
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

4.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

5.  Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).

Authors:  Mario E Lacouture; John C Morris; Donald P Lawrence; Antoinette R Tan; Thomas E Olencki; Geoffrey I Shapiro; Bruce J Dezube; Jay A Berzofsky; Frank J Hsu; Joan Guitart
Journal:  Cancer Immunol Immunother       Date:  2015-01-13       Impact factor: 6.968

Review 6.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

7.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis.

Authors:  Mireia Berdiel-Acer; Daniel Cuadras; Natalia Guillén Díaz-Maroto; Xavier Sanjuan; Teresa Serrano; Antoni Berenguer; Victor Moreno; Samuel Gonçalves-Ribeiro; Ramon Salazar; Alberto Villanueva; David G Molleví
Journal:  Mol Cancer Res       Date:  2014-05-14       Impact factor: 5.852

9.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  22 in total

1.  Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.

Authors:  Sara Rapic; Christel Vangestel; Jeroen Verhaeghe; Tim Van den Wyngaert; Rukun Hinz; Marleen Verhoye; Patrick Pauwels; Steven Staelens; Sigrid Stroobants
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

2.  A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.

Authors:  Wanbin Yang; Xiuli Gong; Xiulian Wang; Chao Huang
Journal:  Invest New Drugs       Date:  2018-11-29       Impact factor: 3.850

3.  Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.

Authors:  Julie Jacobs; Vanessa Deschoolmeester; Karen Zwaenepoel; Tal Flieswasser; Christophe Deben; Jolien Van den Bossche; Christophe Hermans; Christian Rolfo; Marc Peeters; Olivier De Wever; Filip Lardon; Vasiliki Siozopoulou; Evelien Smits; Patrick Pauwels
Journal:  Oncoimmunology       Date:  2018-03-19       Impact factor: 8.110

4.  Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.

Authors:  Xiu-Lian Wang; Chao Huang
Journal:  Mol Biol Rep       Date:  2019-03-05       Impact factor: 2.316

Review 5.  FGFs: crucial factors that regulate tumour initiation and progression.

Authors:  Qian Jing; Yuanyuan Wang; Hao Liu; Xiaowei Deng; Lin Jiang; Rui Liu; Haixing Song; Jingyi Li
Journal:  Cell Prolif       Date:  2016-07-07       Impact factor: 6.831

6.  Looking beyond the cancer cell for effective drug combinations.

Authors:  Jonathan R Dry; Mi Yang; Julio Saez-Rodriguez
Journal:  Genome Med       Date:  2016-11-25       Impact factor: 11.117

Review 7.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.

Authors:  Dimakatso Alice Senthebane; Arielle Rowe; Nicholas Ekow Thomford; Hendrina Shipanga; Daniella Munro; Mohammad A M Al Mazeedi; Hashim A M Almazyadi; Karlien Kallmeyer; Collet Dandara; Michael S Pepper; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

8.  Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study.

Authors:  Rahul Agarwal; Yuan Cao; Klaus Hoffmeier; Nicolas Krezdorn; Lukas Jost; Alejandro Rodriguez Meisel; Ruth Jüngling; Francesco Dituri; Serena Mancarella; Björn Rotter; Peter Winter; Gianluigi Giannelli
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

9.  Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue.

Authors:  Tetsuya Ishikawa
Journal:  World J Stem Cells       Date:  2017-05-26       Impact factor: 5.326

10.  Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.

Authors:  Bingrui Li; Guangsheng Pei; Jun Yao; Qingqing Ding; Peilin Jia; Zhongming Zhao
Journal:  Oncogene       Date:  2021-06-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.